Ambu A/S: directors' dealings · Denmark · Finanstilsynet DK DK:ambu-as DK0060946788 DK DK · Finanstilsynet DK Mcap 34.9Bn€ Healthcare
Explore the full insider trade history of Ambu A/S, a publicly traded company based in Denmark. Shares are listed on DK DK, under the supervision of Finanstilsynet DK. Operating in the Healthcare sector, Ambu A/S has recorded 226 insider filings. Market capitalisation: €34.9bn. The latest transaction was reported on 7 May 2026 — Other. Among the most active insiders: Unknown. Every trade is openly available.
Financial data FY ended September 2024 · cache
Income statement
Revenue 5.39 Bn€
Gross profit 3.20 Bn€ 59% margin
Net income 235.0 M€ 4.4% margin
Balance sheet & cash
Market cap 34.94 Bn€
Total debt 558.0 M€
Free Cash Flow 524.0 M€
Last declaration on 7 May 2026
Declarations 226 total
Executives ● Other3 DK FSA
Share
DK:1440637 · 7 May 2026
Executives ● Other5 DK FSA
Share
DK:1411891 · 5 Jan 2026
Executives ● Other5 DK FSA
Share
DK:1399715 · 10 Nov 2025
Executives ● Other5 DK FSA
Share
DK:1399503 · 7 Nov 2025
Executives ● Purchase5 DK FSA
€6 3 shares @ €2.0106 0.0000% mcap 0.0% of flow DK0060946788⌘
DK:1363832 · 16 May 2025
Ideal exit: 10 Feb 2026 (T+270) Executives ● Other5 DK FSA
Share
DK:1362835 · 13 May 2025
Executives ● Other5 DK FSA
Share
DK:1331427 · 3 Dec 2024
Executives ● Purchase5 DK FSA
€114,708 7,500 shares @ €15.2943 0.0003% mcap 0.0% of flow DK0060946788⌘
DK:1329466 · 22 Nov 2024
Ideal exit: 19 Aug 2025 (T+270) Executives ● Other5 DK FSA
Share
DK:1329465 · 22 Nov 2024
Executives ● Other5 DK FSA
Share
DK:1326558 · 7 Nov 2024
Executives ● Purchase5 DK FSA
€198,769 12,500 shares @ €15.9015 0.0006% mcap 0.1% of flow DK0060946788⌘
DK:1274021 · 9 Feb 2024
Ideal exit: 5 Nov 2024 (T+270) Executives ● Grant5 DK FSA
040,564 shares 0DK0060946788⌘
Share Outside trading venueDK:1240445 · 28 Jul 2023
Executives ● Purchase5 DK FSA
€15,636 1,400 shares @ €11.1686 0.0000% mcap 0.0% of flow DK0060946788⌘
DK:1194499 · 29 Nov 2022
Ideal exit: 26 Aug 2023 (T+270) Executives ● Purchase5 DK FSA
€406,215 41,333 shares @ €9.8279 0.0012% mcap 0.1% of flow DK0060946788⌘
DK:1178117 · 29 Aug 2022
Ideal exit: 26 May 2023 (T+270) Executives ● Sale5 DK FSA
€133,459 5,000 shares @ €26.6919 0.0004% mcap 0.0% of flow DK0060946788⌘
DK:1127474 · 26 Nov 2021
Executives ● Purchase6 DK FSA
€3m 137,600 shares @ €25.3852 0.0100% mcap 0.9% of flow DK0060946788⌘
DK:1112603 · 30 Aug 2021
Ideal exit: 27 May 2022 (T+270) Executives ● Purchase5 DK FSA
€10,401 328 shares @ €31.7089 0.0000% mcap 0.0% of flow DK0060946788⌘
Share Outside a trading venue (shares received after vesting will be listed onDK:1034032 · 26 May 2021
Ideal exit: 20 Feb 2022 (T+270) Executives ● Purchase5 DK FSA
€19,818 625 shares @ €31.7089 0.0001% mcap 0.0% of flow DK0060946788⌘
Share Outside a trading venue (shares received after vesting will be listed onDK:1034030 · 26 May 2021
Ideal exit: 20 Feb 2022 (T+270) Executives ● Purchase5 DK FSA
€134,218 4,358 shares @ €30.7981 0.0004% mcap 0.0% of flow DK0060946788⌘
Share Nasdaq Copenhagen XCSEDK:1034028 · 27 May 2021
Ideal exit: 21 Feb 2022 (T+270) Executives ● Other5 DK FSA
07,254 shares 0DK0060946788⌘
Share Outside a trading venueDK:1002241 · 29 Jan 2021
Executives ● Other5 DK FSA
025,951 shares 0DK0060946788⌘
Share Outside a trading venueDK:1002239 · 29 Jan 2021
Executives ● Purchase5 DK FSA
€269,415 10,017 shares @ €26.8958 0.0008% mcap 0.1% of flow DK0060946788⌘
DK:976599 · 9 Dec 2020
Ideal exit: 5 Sept 2021 (T+270) Executives ● Purchase5 DK FSA
€995,864 39,000 shares @ €25.535 0.0029% mcap 0.3% of flow DK0060946788⌘
DK:976293 · 7 Dec 2020
Ideal exit: 3 Sept 2021 (T+270) Executives ● Purchase5 DK FSA
€723,008 46,883 shares @ €15.4215 0.0021% mcap 0.2% of flow DK0060946788⌘
DK:963257 · 16 Nov 2020
Ideal exit: 13 Aug 2021 (T+270) Executives ● Other7 DK FSA
€5m 175,000 shares @ €27.9344 0.014% mcap 1.2% of flow DK0060946788⌘
DK:963258 · 13 Nov 2020
25 of 226 declarations
Load more (201 remaining) About Ambu A/S Ambu A/S is a Danish company that specializes in the development and manufacturing of medical devices. It primarily focuses on products for resuscitation, anesthesia, and patient monitoring.